Global Micro Guide Catheters Market -2024-2031

Global Micro Guide Catheters Market -2024-2031

Global Micro Guide Catheters Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

The micro guide catheters channel includes information on radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technology to reduce dose, including interactive reconstruction software. Also, microguide catheters are a critical aspect of medical procedures involving ionising radiation to ensure patient safety and optimise imaging outcomes. Efforts are made globally to monitor, optimise, and reduce patient exposure to medical radiation.



Market Dynamics: Drivers & Restraints

Rise in prevalence of cardiovascular diseases

The rise in the prevalence of cardiovascular diseases is one of the significant factor that drives the market to grow during the forecast period. Microguide catheters play a crucial role in managing and treating these diseases once they occur. The increase in cardiovascular disease prevalence is influenced by various factors, including lifestyle choices, genetics, ageing populations, and changes in diagnostic criteria and healthcare access. However, microguide catheters, along with other advanced medical technologies, help improve outcomes for individuals already affected by cardiovascular diseases by enabling more precise and minimally invasive interventions.

For instance, according to the Centers for Disease Control and Prevention (CDC), heart attacks occur every 40 seconds in the US, with 805,000 people experiencing one annually. Of these, 605,000 are first-time heart attacks, while 200,000 are those who have already experienced one. About 1 in 5 heart attacks are silent, causing damage without the person's awareness. Hence, the rise in cardiovascular diseases indeed increases the demand for the microguide catheters market.

Furthermore, global micro guide catheters are also driven by various other factors like a rise in advancements of devices, increasing prevalence of minimally invasive surgeries and others helping the market to grow during the forecast period.

Stringent regulatory requirements

The market growth of micro guide catheters is hindered by various factors which include high costs, lack of skilled professionals, rigorous regulatory requirements, competition from alternative technologies, risks and potential complications, limited reimbursement policies in some countries, and poor awareness of their benefits among the population.

For more details on this report – Request for Sample

Segment Analysis

The global micro guide catheters market is segmented based on product type, therapeutic area, end-user and region.

The over-the-wire catheters from the product type segment accounted for approximately 54.1% of the micro guide catheters market share

The over-the-wire catheters from the product type segment accounted for approximately 54.1%. Over-the-wire microguide catheters are expected to grow during the forecast period owing to the factors like increased usage in various interventional procedures, such as peripheral vascular, neurovascular, and cardiac interventions. The growing patient population, rapid technological advancements, and demand for minimally invasive procedures with smaller, more flexible catheters are also driving this segmental growth.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like due to proper infrastructure and increasing patient compliance with the new technologically advanced treatment, novel product launches and FDA approvals. Also, the rapid increase in the patient pool in the United States tends to increase the demand for these catheters.

For instance, in February 2024, BIOTRONIK stated the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI). This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions). Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.

Covid 19 Impact Analysis

The COVID-19 pandemic has significantly impacted the micro guide catheters market, with a decrease in demand due to the halt of elective surgeries and prioritisation of COVID-19 patients. The global supply chains have been severely impacted, leading to a shortage of components for microguide catheter manufacturing. Some market participants have shifted resources and R&D investments to the development of the COVID-19 vaccine, temporarily limiting the R&D scope of micro-guide catheters.

Market Segmentation

By Product Type
• Over the Wire Micro Guide Catheters
• Flow Directed Micro Guide Catheters

By Therapeutic Area
• Cardiovascular
• Neurovascular
• Urology
• Others

By End User
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Terumo Europe N.V, Medtronic Plc, Johnson & Johnson Limited, ASAHI INTECC Company Limited, Boston Scientific Corporation, Cordis Corporation, Eurocor GmbH, Alvimedica, B Braun Medical, Nipro Medical among others.

Key Developments

 In June 2023, Sensome, a leading medical device company and Asahi Intecc Co. Ltd, a company producing ultra-fine wires for medical use partnered to launch next-generation ClotildSmart Guidewire. It incorporates artificial intelligence to offer crucial information during the surgery for physicians to make more informed decisions. This partnership will help companies manufacture high-end medical devices simplifying complex surgeries.

 In July 2021, Medtronic plc, a global leader in medical technology launched a Prevail Drug Coated Balloon (DCB) catheter in Europe. This DCB catheter is used during percutaneous coronary intervention procedures to treat narrowed coronary arteries in patients with coronary artery diseases.

Why Purchase the Report?
• To visualize the global micro guide catheters market segmentation based on product type, therapeutic area, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of the micro guide catheters market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global micro guide catheters market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies